Get the Stockscreener App
0.4972
0.72%
-0.0036
After Hours:
.49
-0.0072
-1.45%
Century Therapeutics Inc stock is traded at $0.4972, with a volume of 273.40K.
It is down -0.72% in the last 24 hours and down -11.50% over the past month.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
See More
Previous Close:
$0.5008
Open:
$0.519
24h Volume:
273.40K
Relative Volume:
0.33
Market Cap:
$42.95M
Revenue:
$2.24M
Net Income/Loss:
$-136.67M
P/E Ratio:
-0.2171
EPS:
-2.29
Net Cash Flow:
$-102.08M
1W Performance:
-2.57%
1M Performance:
-11.50%
6M Performance:
-16.62%
1Y Performance:
-68.93%
1-Day Range:
$0.49
$0.519
1-Week Range:
$0.49
$0.5193
52-Week Range:
$0.3418
$1.8599
Century Therapeutics Inc Stock (IPSC) Company Profile
Name
Century Therapeutics Inc
Sector
Industry
Phone
215-981-4000
Address
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Compare IPSC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IPSC
Century Therapeutics Inc
|
0.4972 | 43.26M | 2.24M | -136.67M | -102.08M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.21 | 101.15B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.14 | 61.07B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.59 | 59.35B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.83 | 46.29B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.27 | 35.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-24 | Initiated | Rodman & Renshaw | Buy |
| Aug-28-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-27-22 | Initiated | Chardan Capital Markets | Buy |
| Oct-31-22 | Initiated | Guggenheim | Buy |
| Oct-10-22 | Initiated | Canaccord Genuity | Buy |
| May-23-22 | Initiated | H.C. Wainwright | Buy |
| May-12-22 | Initiated | William Blair | Mkt Perform |
| Jul-13-21 | Initiated | BofA Securities | Buy |
| Jul-13-21 | Initiated | JP Morgan | Overweight |
| Jul-13-21 | Initiated | Piper Sandler | Overweight |
View All
Century Therapeutics Inc Stock (IPSC) Latest News
Price momentum metrics for Century Therapeutics Inc. explainedPortfolio Performance Report & Reliable Entry Point Trade Alerts - newser.com
Relative strength of Century Therapeutics Inc. in sector analysisJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com
How to build a dashboard for Century Therapeutics Inc. stockTrade Exit Summary & Verified Stock Trade Ideas - newser.com
Top chart patterns to watch in Century Therapeutics Inc.Product Launch & Reliable Entry Point Alerts - newser.com
Century Therapeutics Inc. recovery potential after sell offPortfolio Risk Report & Free Long-Term Investment Growth Plans - newser.com
Forecasting Century Therapeutics Inc. price range with options dataQuarterly Portfolio Report & Consistent Growth Equity Picks - newser.com
Momentum divergence signals in Century Therapeutics Inc. chartJuly 2025 Trends & Precise Swing Trade Entry Alerts - newser.com
Is Century Therapeutics Inc. stock ready for a breakoutJuly 2025 Pullbacks & Safe Capital Growth Plans - newser.com
Using data models to predict Century Therapeutics Inc. stock movementMarket Trend Review & Community Verified Watchlist Alerts - newser.com
How to escape a deep drawdown in Century Therapeutics Inc.Weekly Gains Summary & Scalable Portfolio Growth Methods - newser.com
When is the best time to exit Century Therapeutics Inc.Trade Analysis Summary & Daily Profit Maximizing Tips - newser.com
Chart based exit strategy for Century Therapeutics Inc.July 2025 Pullbacks & Long-Term Growth Plans - Newser
Ranking Century Therapeutics Inc. among high performing stocks via toolsAnalyst Upgrade & Short-Term High Return Strategies - Newser
Using RSI to spot recovery in Century Therapeutics Inc.July 2025 Reactions & Low Risk Entry Point Guides - Newser
Published on: 2025-09-12 19:08:54 - Newser
Can Century Therapeutics Inc. hit a new high this month2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser
What moving averages say about Century Therapeutics Inc.2025 Short Interest & Daily Risk Controlled Trade Plans - Newser
Will Century Therapeutics Inc. stock go up soonTrade Entry Summary & High Yield Equity Trading Tips - Newser
Multi factor analysis applied to Century Therapeutics Inc.Weekly Stock Report & Free High Return Stock Watch Alerts - Newser
Real time social sentiment graph for Century Therapeutics Inc.Earnings Trend Report & Long Hold Capital Preservation Plans - Newser
Trend analysis for Century Therapeutics Inc. this weekMarket Volume Summary & Smart Investment Allocation Insights - Newser
How to use Fibonacci retracement on Century Therapeutics Inc.Market Growth Report & Fast Momentum Entry Tips - Newser
Real time breakdown of Century Therapeutics Inc. stock performance2025 Macro Impact & Capital Protection Trading Alerts - Newser
What MACD signals say about Century Therapeutics Inc.Earnings Risk Summary & High Accuracy Buy Signal Tips - Newser
Statistical indicators supporting Century Therapeutics Inc.’s strengthMarket Growth Summary & Real-Time Volume Analysis - Newser
What earnings revisions data tells us about Century Therapeutics Inc.Market Performance Recap & Fast Exit and Entry Strategy Plans - Newser
Price action breakdown for Century Therapeutics Inc.July 2025 Highlights & Real-Time Volume Analysis - Newser
How to track smart money flows in Century Therapeutics Inc.Market Activity Report & Technical Confirmation Trade Alerts - Newser
Quantitative breakdown of Century Therapeutics Inc. recent moveQuarterly Market Review & AI Enhanced Execution Alerts - Newser
Published on: 2025-09-11 00:04:25 - Newser
Century Therapeutics Inc Stock (IPSC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.33%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):